- Home
- BOSC vs ALXO Comparison
BOSC vs ALXO Comparison
Compare BOSC & ALXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOSC
- ALXO
- Stock Information
- Founded
- BOSC 1990
- ALXO 2015
- Country
- BOSC Israel
- ALXO United States
- Employees
- BOSC N/A
- ALXO N/A
- Industry
- BOSC Computer Communications Equipment
- ALXO Biotechnology: Pharmaceutical Preparations
- Sector
- BOSC Telecommunications
- ALXO Health Care
- Exchange
- BOSC Nasdaq
- ALXO Nasdaq
- Market Cap
- BOSC 29.5M
- ALXO 24.0M
- IPO Year
- BOSC 1996
- ALXO 2020
- Fundamental
- Price
- BOSC $4.71
- ALXO $0.68
- Analyst Decision
- BOSC
- ALXO Strong Buy
- Analyst Count
- BOSC 0
- ALXO 6
- Target Price
- BOSC N/A
- ALXO $3.30
- AVG Volume (30 Days)
- BOSC 87.4K
- ALXO 562.2K
- Earning Date
- BOSC 08-21-2025
- ALXO 08-12-2025
- Dividend Yield
- BOSC N/A
- ALXO N/A
- EPS Growth
- BOSC 35.10
- ALXO N/A
- EPS
- BOSC 0.49
- ALXO N/A
- Revenue
- BOSC $43,688,000.00
- ALXO N/A
- Revenue This Year
- BOSC N/A
- ALXO N/A
- Revenue Next Year
- BOSC N/A
- ALXO N/A
- P/E Ratio
- BOSC $10.09
- ALXO N/A
- Revenue Growth
- BOSC 0.84
- ALXO N/A
- 52 Week Low
- BOSC $2.50
- ALXO $0.40
- 52 Week High
- BOSC $5.50
- ALXO $2.79
- Technical
- Relative Strength Index (RSI)
- BOSC 40.77
- ALXO 64.14
- Support Level
- BOSC $4.84
- ALXO $0.44
- Resistance Level
- BOSC $5.02
- ALXO $0.64
- Average True Range (ATR)
- BOSC 0.19
- ALXO 0.06
- MACD
- BOSC -0.04
- ALXO 0.02
- Stochastic Oscillator
- BOSC 2.50
- ALXO 84.35
About BOSC B.O.S. Better Online Solutions
BOS Better Online Solutions Ltd is a provider of Intelligent Robotics and Supply Chain solutions for enterprises. The company manages its business in three reportable divisions: the Intelligent Robotics segment, the RFID Division segment, and the Supply Chain Solutions segment. The majority of revenue derives from Supply Chain Solutions which distributes electro-mechanical components, mainly to customers in the aerospace, defense, and other industries, and is a supply chain service provider for aviation customers that seek a comprehensive solution to their components-supply needs. Geographically company derives the majority of its revenue from Israel.
About ALXO ALX Oncology Holdings Inc.
ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.